O'Shaughnessy Asset Management’s Royalty Pharma RPRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.14M	Buy	31,721 +7,911	+33%	+$467K	0.01%	919
2026 Q2	$1.34M	Sell	23,810 -3,630	-13%	-$189K	0.01%	1106
2026 Q1	$1.32M	Buy	27,440 +4,872	+22%	+$213K	0.01%	1061
2025 Q4	$872K	Buy	22,568 +43	+0.2%	+$1.64K	﹤0.01%	1213
2025 Q3	$795K	Buy	22,525 +2,399	+12%	+$86.8K	﹤0.01%	1228
2025 Q2	$725K	Buy	20,126 +2,141	+12%	+$70.9K	﹤0.01%	1193
2025 Q1	$560K	Buy	+17,985	New	+$570K	﹤0.01%	1261
2024 Q4	–	Sell	-10,898	Closed	-$304K	–	2280
2024 Q3	$304K	Buy	+10,898	New	+$302K	﹤0.01%	1484

Other funds holding RPRX

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

O'Shaughnessy Asset Management's RPRX Position: Q3 2026 in Review

O'Shaughnessy Asset Management increased its Royalty Pharma (RPRX) stake by 33% in Q3 2026, buying an estimated $467K and bringing the position to 31,721 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #919.

O'Shaughnessy Asset Management first reported a position in RPRX in Q3 2024 and has held it in 8 quarters since. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

O'Shaughnessy Asset Management held 31,721 shares of Royalty Pharma worth $2.14M as of Q3 2026.
O'Shaughnessy Asset Management bought 7,911 Royalty Pharma shares in Q3 2026, an estimated $467K.
Royalty Pharma made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q3 2026, its #919 holding.
O'Shaughnessy Asset Management first reported a position in Royalty Pharma in Q3 2024 and has held it in 8 quarters since.
573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.